SC 13G

Company

Hepion Pharmaceuticals, Inc.

Filed

July 24, 2018

Accession Number

0001193125-18-224755

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →